Figure 1.

Siah2 was expressed in CML patients and cell lines. (A) Siah2 mRNA expressions, on QPCR, of CML-CP patients, CML-BC patients, and healthy controls. (B) Siah2 protein immunoreactivity, on western blots, of CML-CP patients, CML-BC patients and healthy controls. β-actin served as a loading control. (C) Siah2 mRNA expressions of K562 and K562-R cells were analyzed via QPCR. (D) Siah2 protein expressions of cell lines were analyzed via western blots. Kruskal-Wallis test was employed, whereby statistical significance was obtained for continuous variables using a non-parametric analysis of variance. For statistical significance, patient groups were compared by employing Dunn’s multiple-comparison test. ** P<0.01.